SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-23-034605 from Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)

Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: Sept. 28, 2023 · CIK: 0001106838 · Accession: 0001493152-23-034605

AI Filing Summary & Sentiment

File numbers found in text: 333-274581

Date
September 28, 2023
Author
By
Form
CORRESP
Company
Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)

Letter

Re: Sonnet BioTherapeutics Holdings, Inc.

September 28, 2023

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-1

File No. 333-274581

Ladies and Gentlemen:

Sonnet BioTherapeutics Holdings, Inc. hereby requests that its acceleration request dated September 28, 2023 be withdrawn. Please call Tracy F. Buffer of Lowenstein Sandler LLP at (973) 597-2434 with any questions.

Sincerely,
SONNET BIOTHERAPEUTICS HOLDINGS, INC.

Show Raw Text
CORRESP
1
filename1.htm

September
28, 2023

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    Sonnet BioTherapeutics Holdings,
    Inc.

    Registration Statement on Form S-1

    File No. 333-274581

Ladies
and Gentlemen:

Sonnet
BioTherapeutics Holdings, Inc. hereby requests that its acceleration request dated September 28, 2023 be withdrawn. Please call Tracy
F. Buffer of Lowenstein Sandler LLP at (973) 597-2434 with any questions.

    Sincerely,

    SONNET BIOTHERAPEUTICS HOLDINGS, INC.

    By:
    /s/
    Pankaj Mohan

    Name:
    Pankaj Mohan

    Title:
    Chief Executive Officer